Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.87 +0.01 (+0.54%)
At close: Nov 11, 2026 · 4:00 PM EST

Lexicon Pharmaceuticals (LXRX) Gains from Sales and Divestitures (2009 - 2020)

Updated

Lexicon Pharmaceuticals (LXRX) recorded Gains from Sales and Divestitures of -$3,000 in FY2022, compared with -$49,000 in FY2021.

Analysis

Lexicon Pharmaceuticals (LXRX) Gains from Sales and Divestitures (2009 - 2020) Analysis & Trends

Starting with FY2014, Lexicon Pharmaceuticals' Gains from Sales and Divestitures history includes 7 years.

  • Per Business Quant data, LXRX's Gains from Sales and Divestitures was -$49,000 in FY2021 and $707,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Lexicon Pharmaceuticals 831.26 Mn 190.55 Mn 11.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 133.53 Mn
Dec 31, 2017 -1,000.00
Jun 30, 2017 -2,000.00
Dec 31, 2016 -4,000.00
Sep 30, 2016 -24,000.00
Mar 31, 2016 12,000.00
Dec 31, 2015 94,000.00
Sep 30, 2015 12,000.00
Jun 30, 2015 -65,000.00
Mar 31, 2015 6,000.00
Dec 31, 2014 2.44 Mn
Sep 30, 2014 -78,000.00
Jun 30, 2014 -469,000.00
Mar 31, 2014 -264,000.00
Sep 30, 2011 79,000.00
Jun 30, 2011 46,000.00
Mar 31, 2011 -31,000.00
Sep 30, 2010 -62,000.00
Sep 30, 2009 -19,000.00
Jun 30, 2009 2,000.00
API Access

Lexicon Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LXRX&period=max&api_key=YOUR_API_KEY